News of the deal for Johnson and Johnson Stock to acquire Actelion for $30 billion has JNJ Stock lower today. Jan 26 2017.
$30 billion is certainly a large sum of money to be paying, but Johnson and Johnson has been sitting on a pile of Euros for a long-time and now they can finally apply some of that cash.
The acquisition gives Johnson and Johnson access to the Actelion’s line-up of high-price, high-margin medicines for rare diseases which will help them diversify product lines still further.
Here are the details of the multiple trades done today. I have also outlined the outlook for the stock for the next several weeks and my next trades in the stock………..The rest of this trade alert and discussion is for FullyInformed Members.
Johnson and Johnson Stock Trade Alert for Jan 26 2017